Dr. Ahmed A. Abd-Rabou
My Social Links

Dr. Ahmed A. Abd-Rabou

Researcher
National Research Center, Egypt

Highest Degree
Ph.D. in Biochemistry and Molecular Biology from Cairo University, Egypt

Share this Profile

Area of Interest:

Molecular Sciences
100%
Clinical Microbiology
62%
Molecular Biology
90%
Biochemistry
75%
Cell Biology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Abd-Rabou, A.A., E.A. Assirey, R. Saad and H.S. Ibrahim, 2018. Metallocenes-induced apoptosis in human hepatic cancer HepG2 cells: The prodigy of zamzam water. Int. J. Pharmacol., 14: 260-270.
    CrossRef  |  Direct Link  |  
  2. Abd-Rabou, A.A., D.J. Bharali and S.A. Mousa, 2018. Taribavirin and 5-Fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking and antiproliferative effects on MCF-7 breast cancer. Pharm. Res., Vol. 35, No. 4. 10.1007/s11095-017-2283-3.
    CrossRef  |  Direct Link  |  
  3. Abd-Rabou, A.A., B.F. Abdel-Wahab and M.S. Bekheit, 2018. Synthesis, molecular docking and evaluation of novel bivalent pyrazolinyl-1, 2, 3-triazoles as potential VEGFR TK inhibitors and anti-cancer agents. Chem. Pap., 42: 2225-2237.
    CrossRef  |  Direct Link  |  
  4. Zoheir, K.M., G.I. Harisa, A.A. Allam, L. Yang and X. Li et al., 2017. Effect of alpha lipoic acid on in vitro development of bovine secondary preantral follicles. Theriogenology, 88: 124-130.
    CrossRef  |  Direct Link  |  
  5. Shalby, A.B., A.A. Abd-Rabou and H.H. Ahmed, 2017. Nano-Se crosstalks with nano-DOX/FU to selectively hack hepatic cancer cells and spare normal cells healthy: A mechanism-based study. J. Applied Pharm. Sci., 7: 3-12.
    Direct Link  |  
  6. Abd-Rabou, A.A., S.H. Mohamed, M.A. Mwaheb, O.N. Sayed and M.S. Kishta, 2017. Metaformin-based regimen inhibits glucose uptake and G6PD activity: A de novo Anti-cervical cancer strategy tackles HeLa and its derivative Hep2 cells. J. Pharmacol. Toxicol., 12: 76-86.
    CrossRef  |  Direct Link  |  
  7. Abd-Rabou, A.A., H.H. Ahmed and E.F. Eskander, 2017. Clemastine, the H1 histamine Receptor antagonist, alters the human sex and thyroid hormonal profiles. Asian J. Pharm. Clin. Res., 10: 327-330.
    CrossRef  |  Direct Link  |  
  8. Abd-Rabou, A.A., A.M. Abdalla, N.A. Ali and K.M.A. Zoheir, 2017. Moringa oleifera root induces cancer apoptosis more effectively than leave nanocomposites and its free counterpart. Asian Pac. J. Cancer Prev., 18: 2141-2149.
    CrossRef  |  Direct Link  |  
  9. Abd-Rabou, A.A., 2017. Calcium, a cell cycle commander, drives colon cancer cell diffpoptosis. Indian J. Clin. Biochem., 32: 9-18.
    CrossRef  |  Direct Link  |  
  10. Abd-Rabou, A.A. and H.H. Ahmed, 2017. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line. Adv. Med. Sci., 62: 357-367.
    CrossRef  |  Direct Link  |  
  11. Abd-Rabou, A.A. and A.E. Edris, 2017. Evaluation of the antiproliferative activity of some nanoparticulate essential oils formulated in microemulsion on selected human carcinoma cell lines. Curr. Clin. Pharmacol., 12: 231-244.
    CrossRef  |  Direct Link  |  
  12. Zoheir, K.M., A.A. Abd-Rabou, G.I. Harisa, A. Kumar, S.F. Ahmad, M.A. Ansari and A.R. Abd-Allah, 2016. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells. Tumor Biol., 37: 13927-13939.
    CrossRef  |  Direct Link  |  
  13. Elbaz, N.M., I.A. Khalil, A.A. Abd-Rabou and I.M. El-Sherbiny, 2016. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. Int. J. Biol. Macromol., 92: 254-269.
    CrossRef  |  Direct Link  |  
  14. Ahmed, H.H., H.A. Aglan and A.A. Abd-Rabou, 2016. Stem Cells and Neurodegenerative Diseases. In: Developmental and Stem Cell Biology in Health and Disease, El-Hashash, A. (Ed.). Bentham Science, USA., ISBN: 978-1-68108-220-2, pp: 166-192.
  15. Ahmed, H.H., H.A. Aglan and A.A. Abd-Rabou, 2016. Stem Cells and Bone Disorders. In: Developmental and Stem Cell Biology in Health and Disease, El-Hashash, A. (Ed.). Bentham Science, USA., ISBN: 978-1-68108-220-2, pp: 193-209.
  16. Abd-Rabou, A.A., K.M.A. Zoheir, M.S. Kishta, A.B. Shalby and M.I. Ezzo, 2016. Nano-micelle of Moringa oleifera seed oil triggers mitochondrial cancer cell apoptosis. Asian Pac. J. Cancer Prev., 17: 4929-4933.
    CrossRef  |  Direct Link  |  
  17. Zoheir, K.M., A.A. Abd-Rabou, G.I. Harisa, A.E. Ashour and S.F. Ahmad et al., 2015. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression. Int. J. Clin. Exp. Pathol., 8: 8821-8831.
    Direct Link  |  
  18. Belousova, V., A.A. Abd-Rabou and S.A. Mousa, 2015. Recent advances and future directions in the management of hepatitis C infections. Pharmacol. Ther., 145: 92-102.
    CrossRef  |  Direct Link  |  
  19. Ahmed, H.H., A.A. Abd-Rabou, A.Z. Hassan and S.E. Kotob, 2015. Phytochemical analysis and anti-cancer investigation of Boswellia serrata bioactive constituents in vitro. Asian Pac. J. Cancer Prev., 16: 7179-7188.
    PubMed  |  
  20. Abd-Rabou, A.A., E.F. Eskander, M.S. Mohamed, S.M. Yahya, A. El Sherbini and O.G. Shaker, 2015. P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy. Genes Dis., 2: 197-210.
    CrossRef  |  Direct Link  |  
  21. Abd-Rabou, A.A. and E.F. Eskander, 2015. Genetic Signatures for Progression and Response of Hepatitis C. Subtitle: Apoptosis and Hepatitis C: Genetic and Hormonal Predictors. Lambert Academic Publishing, Germany, ISBN: 978-3-659-77056-2, Pages: 221.
  22. Refaat, A., A. Abd-Rabou and A. Reda, 2014. TRAIL combinations: The new ‘trail’ for cancer therapy. Oncol. Lett., 7: 1327-1332.
    CrossRef  |  Direct Link  |  
  23. Eskander, E.F., A.A. Abd-Rabou, S.M. Yahya, A. El Sherbini, M.S. Mohamed and O.G. Shaker, 2014. The impact of Pegylated-interferon-α plus ribavirin on prolactinemia and testosteronemia among hepatitis C-Genotype-4a patients. Open J. Biochem., 2: 1-8.
  24. Eskander, E.F., A.A. Abd-Rabou, S.M. Yahya, A. El Sherbini, M.S. Mohamed and O.G. Shaker, 2014. P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences. Indian J. Clin. Biochem., 29: 3-7.
    CrossRef  |  Direct Link  |  
  25. Eskander, E.F., A.A. Abd-Rabou, M.S. Mohamed, S.M. Yahya, A. El Sherbini and O.G. Shaker, 2014. The potential impact of P53 and APO-1 genetic polymorphisms on hepatitis C genotype 4a susceptibility. Gene, 550: 40-45.
    CrossRef  |  Direct Link  |  
  26. Eskander, E.F., A.A. Abd-Rabou, S.M. Yahya, A. El Sherbini, M.S. Mohamed and O.G. Shaker, 2013. Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response. Indian J. Clin. Biochem., 28: 348-357.
    CrossRef  |  Direct Link  |  
  27. Eskander, E.F., A.A. Abd-Rabou and H.H. Ahmed, 2013. The impact of digestive and colon drugs on the human hormones profile. Indian J. Clin. Biochem., 28: 413-417.
    CrossRef  |  Direct Link  |  
  28. Eskander, E.F., A.A. Abd-Rabou and H.H. Ahmed, 2013. Does anti-gout agent allopurinol affect human hormones profile? J. Applied Pharm. Sci., 3: 79-82.
    Direct Link  |  
  29. Ahmed, H.H. and A.A. Abd-Rabou, 2013. Hormones as diagnostic, prognostic and therapeutic tools for breast cancer. Global J. Breast Cancer Res., 1: 71-84.
  30. Eskander, E.F., S.F. Estefan and A.A. Abd-Rabou, 2012. How does long term exposure to base stations and mobile phones affect human hormone profiles? Clin. Biochem., 45: 157-161.
    CrossRef  |  Direct Link  |  
  31. Eskander, E.F., A.A. Abd-Rabou, S.M.M. Yahya, O.G. Shaker and M.S. Mohamed, 2012. Does interferon and ribavirin combination therapy ameliorate growth hormone deficiency in HCV genotype-4 infected patients? Clin. Biochem., 45: 3-6.
    CrossRef  |  Direct Link  |  
  32. Eskander, E.F., A.A. Abd-Rabou, M.S. Mohamed, S.M. Yahya and O.G. Shaker, 2012. Does HCV patients who have BCL2 43Ala genotype and normal GH1 levels can achieve response to IFN based therapy? Indian J. Clin. Biochem., 27: 344-350.
    CrossRef  |  Direct Link  |  
  33. Abd-Rabou, A.A., K.M.A. Zoheir and H.H. Ahmed, 2012. Potential impact of curcumin and taurine on human hepatoma cells using Huh-7 cell line. Clin. Biochem., 45: 1519-1521.
    CrossRef  |  Direct Link  |  
  34. Abd-Rabou, A.A., E.F. Eskander and S.M.M. Yahya, 2012. BCL-2 Gene Polymorphisms and hGH Levels in HCV Patients: Molecular Genetic and Hormonal Biomarkers for HCV Response to IFN/RBV Combination Therapy. LAP LAMBERT Academic Publishing, Germany, Pages: 168.
  35. Shaker, O.G., E.F. Eskander, S.M. Yahya, M.S. Mohamed and A.A. Abd-Rabou, 2011. Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patients. Clin. Chim. Acta, 412: 593-598.
    CrossRef  |  Direct Link  |